Regeneron Announces Strong Results in Gout Study

Regeneron Pharmaceuticals of Tarrytown, N.Y., announced positive results from a second late-stage clinical trial showing that its drug Arcalyst, currently approved for a rare disease, can treat gout, a much more lucrative opportunity.
Forbes